	Periodontitis and breast cancer risk: A systematic review with meta-epidemiological analysis. J Periodontol Peitoxo RK, Del Agnese CC, Comassetto MC, Oliveira LM, Miguez PA, Antoniazzi RP. PMID: 42522381 [PubMed - as supplied by publisher]
	De-Escalation of Neoadjuvant Treatment for HER2-Positive Breast Cancer. Int J Cancer Ma Y, Chen D, Huang S. PMID: 42521481 [PubMed - as supplied by publisher]
	12-week resistance training and body composition in women survivors of breast cancer: influence of tumour type and treatments. BMJ Support Palliat Care Esteban-Simón A, Díez-Fernández DM, Gonzalo-Encabo P, Olmedo-Pérez-Montaut M, Rodríguez-Pérez MA, Morales JS, Soriano-Maldonado A. PMID: 42521448 [PubMed - as supplied by publisher]
	One-carbon metabolism nutrients and polygenic risk scores in relation to breast cancer risk: A nested case-control study within the EPIC cohort. Am J Clin Nutr Gálvez-Navas JM, Peruchet-Noray L, Molina-Montes E, Rodríguez-Barranco M, Biessy C, Antoniussen CS, Dahm CC, Kyrø C, Dahl C, Sugier PE, Asgari Y, Truong T, Nicolas G, Turzanski-Fortner R, le Cornet C, Schulze MB, Milani L, Masala G, Quartiroli M, Signoriello S, Tumino R, Crous-Bou M, Mokoroa O, Rodríguez-Palacios D, Trobajo-Sanmartín C, Heath AK, Dossus L, Huybrechts I, Sánchez MJ. PMID: 42520943 [PubMed - as supplied by publisher]
	Adverse Events in a Randomized Trial Comparing Radiotherapy with or without Olaparib for Inflammatory Breast Cancer. Int J Radiat Oncol Biol Phys Jagsi R, Meisner A, Chalasani P, Lew D, Barlow WE, Bellon JR, Henry NL, Matuszak MM, Moran JM, Pierce LJ, Rakovitch E, Reyes SJ, Speers C, Unger JM, White JR, Woodward WA, Zellars RC, Pusztai L, Sharma P. PMID: 42520859 [PubMed - as supplied by publisher]
	Evaluation of the impact of a third mammographic reading in the French population-based breast cancer screening program. Cancer Epidemiol Koïvogui A, Saifi S, Razafija M, Mensah P, Bernoux A, Cherel P, Sellier N. PMID: 42520630 [PubMed - as supplied by publisher]
	A six-phase co-design framework for dual-audience health education in intellectual disabilities: Development and feasibility testing for breast cancer prevention. Patient Educ Couns Kowalczyk O. PMID: 42520598 [PubMed - as supplied by publisher]
	Making patient-oriented decisions with collegial support as an anchor: Oncologists' experiences of late-line treatment selection in metastatic breast cancer. Patient Educ Couns Larsson K, Vestergaard E, Svensson L, Öhrn E, Wärnberg F, Öfverholm A, Ekholm M, Liljedahl M. PMID: 42520597 [PubMed - as supplied by publisher]
	Cardiotoxicity of newer HER2-Directed therapies in breast cancer: A systematic review and meta-analysis of incidence and comparative risk. Breast Sundaramoorthy S, Gokulanathan N, Joseph P R, Tm A, Mathew SP, Kaur H, Muthukumarasamy T, Jose J, Jayaraman KB, Rajmohan P, Thovarayi V, Sathyadas A, Ignatious SV, Valaparambil SA. PMID: 42520572 [PubMed - as supplied by publisher]
	Lipid metabolism in Î³Î´ T-cell activation: Implications for immunotherapy in ovarian cancer. Transl Oncol Stirblyte K, Ghanem Y, Bates M, Gray SG, Saadeh FA, Martin C, O'Toole S, O'Leary JJ, Doherty DG, Mohamed BM. PMID: 42520474 [PubMed - as supplied by publisher]
	RGS Family Remodeling in Breast Cancer: A Meta-Analysis and Multi-Omics Profiling of Prognostic Biomarkers. Cancer Med Mirzaei Z, Moghaddam MM, Barati T, Ebrahimi A, Khaniani MS. PMID: 42520291 [PubMed - as supplied by publisher]
	Stability and interpretability of penalized logistic regression models for breast cancer risk prediction. PLoS One Okyere F, Nyanney M. PMID: 42520065 [PubMed - as supplied by publisher]
	Realist Collaborative Evaluation of a Work Disability Prevention Program for Breast Cancer Survivors: Protocol for a RECOVA-FASTRACS Realist Evaluation. JMIR Res Protoc Blazer A, Rouat S, Guittard L, Drouin P, Péron J, Fervers B, Carretier J, Broc G, Letrilliart L, Fassier JB, Lamort-Bouché M. PMID: 42519964 [PubMed - as supplied by publisher]
	Development and usability testing of a health recommender system for symptom management in women with breast cancer who were receiving or had recently received chemotherapy. Asia Pac J Oncol Nurs Cai T, Chen J, Duan Y, Dai A, Wang L, Yuan C. PMID: 42519179 [PubMed - as supplied by publisher]
	Cross-trait genetic architecture between breast cancer and psychiatric disorders. iScience Wang C, Hu J, Lei Y, Li J, Zhang Y, Hu K, Liu L, Su X, Wang X, Wang J, Wang Y, Jia H. PMID: 42519006 [PubMed - as supplied by publisher]
	Clinicopathological, multimodal treatment, and survival patterns for men with breast cancer in England and Wales: a population-based cohort study. EClinicalMedicine Boyle JM, Withrow D, Blacker S, Wang L, Delon C, Medina J, Dodwell D, Verrill M, Horgan K, Cromwell DA. PMID: 42518938 [PubMed - as supplied by publisher]
	Quality of life and psychological outcomes with albumin-bound paclitaxel-carboplatin versus solvent-based paclitaxel-carboplatin as first-line chemotherapy in stage IC-IV ovarian carcinoma. Gynecol Oncol Rep Mahlawat N, Sood A, Vias P, Sawaraj S. PMID: 42518872 [PubMed - as supplied by publisher]
	Influence of age, body mass index and family income on the health Quality of Life among the breast cancer patients in Bangladesh: a cross-sectional study. Front Oncol Rahman R, Ishika A, Ali TY, Nabi MH, Hawladar MDH, Dalal K. PMID: 42518816 [PubMed - as supplied by publisher]
	Prognostic Significance of Pretreatment Mean Platelet Volume in Patients with Recurrent or De Novo Metastatic Breast Cancer: A Single-Center Retrospective Study. Breast Cancer (Dove Med Press) Gökdere ZS, Günenç D, Sezer S, Geçgel A, Çay . PMID: 42518661 [PubMed - as supplied by publisher]
	Lipid Metabolic Reprogramming in Breast Cancer: Mechanisms and Emerging Therapeutic Strategies. Breast Cancer (Dove Med Press) Wang X, Zhao Y, Peng S, Wang X, Wang Q, Hao S. PMID: 42518660 [PubMed - as supplied by publisher]

Articles 1 - 20 / 332843

Page 1 of 16643



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy